Alignment Healthcare
ALHC
8.55
+0.18
+2.15%
Alignment Healthcare
US · ALHC
#2907 by market cap
Listed 2021
8.55
+0.18
+2.15%
Live - 5344 symbols - heartbeat 103s ago
· 2026-10-08 08:05
Pre-market
8.53
-0.24%
After-hours
8.57
+0.23%
Overnight
8.57
+0.23%
- Market cap
- 1.77B
- P/E (TTM)i
- 45.97
- P/Bi
- 6.69
- EPSi
- 0.00
- Div yieldi
- 0.00%
- 52W posi
- 7%
Reader sentiment
Are you bullish or bearish on ALHC?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 8 analysts
Buy
Avg price target
23.00 +169.0%
Price target rangecurrent 8.55
Low19.00
Avg23.00
High28.00
Buy 100%
Hold 0%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-10-05 | Piper Sandler | -- | BUY | -- |
| 2026-09-15 | William Blair | -- | BUY | -- |
| 2026-08-04 | J.P. Morgan | -- | BUY | 22.00 |
| 2026-08-03 | TD Cowen | -- | BUY | 21.00 |
| 2026-08-03 | Raymond James | -- | BUY | 19.00 |
| 2026-08-02 | Goldman Sachs | -- | BUY | 25.00 |
| 2026-07-31 | KeyBanc | -- | BUY | 28.00 |
| 2026-07-31 | BofA Securities | -- | BUY | -- |
| 2026-07-30 | William Blair | -- | BUY | -- |
| 2026-07-30 | Goldman Sachs | -- | BUY | 25.00 |
| 2026-07-09 | Goldman Sachs | -- | BUY | 25.00 |
| 2026-06-10 | KeyBanc | -- | BUY | 28.00 |
| 2026-05-04 | Goldman Sachs | -- | BUY | 25.00 |
| 2026-05-03 | TD Cowen | -- | BUY | 25.00 |
| 2026-05-01 | KeyBanc | -- | BUY | 28.00 |
| 2026-05-01 | BofA Securities | -- | BUY | 25.00 |
| 2026-04-30 | William Blair | -- | BUY | -- |
| 2026-03-02 | Piper Sandler | -- | BUY | 30.00 |
| 2026-02-27 | TD Cowen | -- | BUY | 25.00 |
| 2026-02-26 | William Blair | -- | BUY | -- |
| 2026-02-05 | J.P. Morgan | -- | BUY | 26.00 |
| 2026-01-30 | Baird | -- | BUY | 28.00 |
| 2026-01-22 | KeyBanc | -- | BUY | 28.00 |
| 2026-01-15 | TD Cowen | -- | BUY | 25.00 |
| 2026-01-14 | UBS | -- | HOLD | 21.00 |
Quant vs Street three independent views, side by side
Momentum strategy signal
Strong Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 1 upgrade vs 0 downgrades among tracked analyst rating changes.
- Most recent: J.P. Morgan moved from Hold to Buy on 2026-02-05.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-02-05 | J.P. Morgan | HOLD → BUY | 26.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-30 | After close | ±13.76% | -20.20% (beat) |
| 2026/Q1 | 2026-04-30 | After close | ±9.81% | -10.12% (beat) |
| 2025/Q4 | 2026-02-26 | After close | ±12.24% | -5.88% (in line) |
| 2025/Q3 | 2025-10-30 | After close | ±12.27% | -1.52% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±19.30% | +6.00% (in line) |
| 2025/Q1 | 2025-05-01 | After close | ±17.95% | -7.39% (in line) |
| 2024/Q4 | 2025-02-27 | After close | ±16.04% | +16.48% (beat) |
| 2024/Q3 | 2024-10-29 | After close | ±22.12% | +0.17% (in line) |
| 2024/Q2 | 2024-08-01 | After close | ±33.90% | +3.71% (in line) |
| 2024/Q1 | 2024-05-02 | After close | ±25.34% | +26.05% (beat) |
| 2023/Q4 | 2024-02-27 | After close | ±21.13% | -18.21% (in line) |
| 2023/Q3 | 2023-11-02 | After close | ±29.02% | -5.20% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 08:05:50 · For reference only, not investment advice and not tailored to your situation.